Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ.

Aharoni R, Kayhan B, Eilam R, Sela M, Arnon R.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14157-62. Epub 2003 Nov 12. Erratum in: Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12288.

2.

Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?

Jee Y, Liu R, Bai XF, Campagnolo DI, Shi FD, Vollmer TL.

Int Immunol. 2006 Apr;18(4):537-44. Epub 2006 Feb 15.

3.
4.

The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice.

Aharoni R, Eilam R, Domev H, Labunskay G, Sela M, Arnon R.

Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19045-50. Epub 2005 Dec 19.

5.

Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications.

Arnon R, Aharoni R.

Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14593-8. Epub 2004 Sep 15.

6.

Glatiramer acetate: mechanisms of action in multiple sclerosis.

Ziemssen T, Schrempf W.

Int Rev Neurobiol. 2007;79:537-70. Review.

PMID:
17531858
7.

Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapy.

Ziemssen T, Kümpfel T, Schneider H, Klinkert WE, Neuhaus O, Hohlfeld R.

J Neurol Sci. 2005 Jun 15;233(1-2):109-12.

PMID:
15869765
8.

Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1.

Aharoni R, Teitelbaum D, Leitner O, Meshorer A, Sela M, Arnon R.

Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11472-7.

9.
10.

The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells.

Aharoni R, Sonego H, Brenner O, Eilam R, Arnon R.

Immunol Lett. 2007 Oct 15;112(2):110-9. Epub 2007 Aug 8.

PMID:
17719654
11.

Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.

Teitelbaum D, Aharoni R, Klinger E, Kreitman R, Raymond E, Malley A, Shofti R, Sela M, Arnon R.

Ann N Y Acad Sci. 2004 Dec;1029:239-49.

PMID:
15681762
12.

Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role.

Liblau R.

J Neurol Sci. 2009 Dec;287 Suppl 1:S17-23. doi: 10.1016/S0022-510X(09)71296-1.

PMID:
20106343
13.

Characterization of T cell lines derived from glatiramer-acetate-treated multiple sclerosis patients.

Qin Y, Zhang DQ, Prat A, Pouly S, Antel J.

J Neuroimmunol. 2000 Aug 1;108(1-2):201-6.

PMID:
10900354
14.
15.

Glatiramer acetate: mechanisms of action in multiple sclerosis.

Schrempf W, Ziemssen T.

Autoimmun Rev. 2007 Aug;6(7):469-75. Epub 2007 Mar 6. Review.

PMID:
17643935
16.

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.

Youssef S, Stüve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, Bravo M, Mitchell DJ, Sobel RA, Steinman L, Zamvil SS.

Nature. 2002 Nov 7;420(6911):78-84.

PMID:
12422218
17.

B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.

Kala M, Rhodes SN, Piao WH, Shi FD, Campagnolo DI, Vollmer TL.

Exp Neurol. 2010 Jan;221(1):136-45. doi: 10.1016/j.expneurol.2009.10.015. Epub 2009 Oct 29.

PMID:
19879259
18.

Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor.

Chen M, Valenzuela RM, Dhib-Jalbut S.

J Neurol Sci. 2003 Nov 15;215(1-2):37-44.

PMID:
14568126
19.

Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells.

Vieira PL, Heystek HC, Wormmeester J, Wierenga EA, Kapsenberg ML.

J Immunol. 2003 May 1;170(9):4483-8.

20.

Glatiramer acetate treatment directly targets CD11b(+)Ly6G(-) monocytes and enhances the suppression of autoreactive T cells in experimental autoimmune encephalomyelitis.

Toker A, Slaney CY, Bäckström BT, Harper JL.

Scand J Immunol. 2011 Sep;74(3):235-43. doi: 10.1111/j.1365-3083.2011.02575.x.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk